Bienaime Jean Jacques
Director | Chief Executive Officer
6 companies
Insider Signal Score
68
StrongTrades Analyzed
59
12M Win Rate
64.3%
Avg 3M Return
+2.4%
Avg 12M Return
+8.5%
Bienaime Jean Jacques is a Director at BIOMARIN PHARMACEUTICAL INC with holdings across 6 companies. Recent SEC Form 4 filings include 0 buys and 19 sells.
Estimated insider holdings value: $30.1M based on current market prices.
Holdings by Company
BMRNMay 20, 2024
Current Shares473.8K
Value$26.48M
Net Activity-2,115,500
Bought: 0Sold: 2.12M
IMNMMar 11, 2026
Current Shares38.4K
Value$736.8K
Net Activity+30.8K
Bought: 30.8KSold: 0
INCYJun 10, 2025
Current Shares20.8K
Value$2.16M
Net Activity-1,522
Bought: 1.0KSold: 2.5K
IMUXSep 24, 2018
Current Shares18.5K
Value$272.9K
Net Activity-6,619
Bought: 40.0KSold: 46.6K
KROSJun 15, 2026
Current Shares17.6K
Value$193.2K
Net Activity+3.0K
Bought: 3.0KSold: 0
ASNDMay 29, 2026
Current Shares900
Value$205.2K
Net Activity+500
Bought: 500Sold: 0
Transaction History
Showing 10 filings (page 4)
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2022 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 25,000 | $83.42 | $2,085,550.00 | -3.6% | +7.0% | +18.1% | |
| Apr 18, 2022 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 20,000 | $81.91 | $1,638,200.00 | -5.6% | +5.3% | +21.2% | |
| Apr 14, 2022 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 10,000 | $83.66 | $836,600.00 | -2.9% | +6.2% | +19.4% | |
| Mar 11, 2022 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 30,000 | $77.69 | $2,330,700.00 | -4.2% | +0.9% | +19.1% | |
| Jan 13, 2022 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 10,000 | $88.43 | $884,300.00 | -1.6% | -4.7% | +27.9% | |
| Dec 16, 2021 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 12,000 | $83.70 | $1,004,340.00 | -1.9% | -3.4% | +30.0% | |
| Dec 1, 2021 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sell | 1,500 | $87.22 | $130,831.50 | -0.5% | -8.4% | +21.9% | |
| May 10, 2021 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 8,513 | $77.29 | $657,969.77 | -2.7% | +1.5% | +4.0% | |
| May 7, 2021 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 50,000 | $78.21 | $3,910,319.31 | -3.1% | +0.2% | +1.9% | |
| Apr 23, 2021 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 20,000 | $79.13 | $1,582,500.00 | -3.2% | -0.3% | +2.2% |